Chapter 3 Flashcards

(33 cards)

1
Q

Corticosteroids Naturally occurring:
( ممكن انه ينعطى او يكون بالجسم ) ومن الشغلات الي بتكون بالجسم:
وبتم افرازهن من ال cortex بال adrenal gland

A

a. Glucocorticoids
b. Mineralocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

a. Glucocorticoids

A

l) Cortisol (hydrocortisone)
2) Corticosterone
3) Cortisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

b. Mineralocorticoids

A

l) Aldosterone
2) Desoxycorticosterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Synthetic preparations of Glucocorticoids:
بتصنف بحسب ال action يعني قديش بظل يشتغل بالدم

  1. Short acting: (12 hours or less):
A

a) Cortisol (hydrocortisone).
b) cortisone.
- short acting, synthetic glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Synthetic preparations of Glucocorticoids:
- Intermediate-acting (12-24 hours)

A

a) Prednisone
b) Prednisolone
c) Methylprednisolone
d) Triamcinolone
- intermediate acting, synthetic glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Synthetic preparations of Glucocorticoids:
- long-acting (More than 48 hours)

A

a) Betamethasone
e) Paramethasone
b) Dexamethasone
c) Flumethasone
- long action, synthetic glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pharmacokinetics:
مهم حفظ.

A
  • 90% of glucocorticoid protein bound - increase half life.
  • is a lipid soluble but absorption rate is low because it is protein bound.
  • Because it is lipid-soluble, it enters the cell easily. - Active transport of bound steroid into cell
  • corticosteroid binding globulin - delivers drug to cell.
  • Albumin binding restricts volume of distributio.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pharmacodynamic:
- Mechanism 1:

A

Inhibit phospholipase A2 -> inhibit arachidonic acid (AA) formation
Inhibit prostaglandin -> antinflammatory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pharmacodynamic:
- Mechanism 2 :

A
  • Binding of glucocorticoid to receptor in cytoplasm and transport to nuclease.
  • complex binding to regulatable gene, causes in increase DNA transcription.
  • proteins may be produced (depending on specific genes activated).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Two receptors in mechanisms:

A
  1. Phospholipase A2.
  2. Transcription factor.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Inhibition phospholipase A2, lead to

A
  • inhibition Thromboxane - antiplatelets effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pharmacological effect :

A
  • antinflammatory
  • antiplatelate aggregation
  • vasoconstriction
  • decrease nociceptors - analgesia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Adverse effect:

A
  1. Ulcer
  2. Bleeding
  3. Immunosuppression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Systemic Effects of Glucocorticoids:
1. Central Nervous System:

A
  • stimulate appetite.
  • Euphoria and behavioral changes, Lower Seizure Threshold.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Systemic Effects of Glucocorticoids:
2. Gastrointestinal tract

A
  • Decreased calcium and iron absorption.
  • facilitated fat absorption.
  • increase acid, pepsin, trypsin (increase digestive)
  • elevate liver enzyme - Alanine aminotransferase (ALT) and gamma-glutamyl transpeptidase (GGT)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Systemic Effects of Glucocorticoids:
3. metabolic action

A
  • increase live glycogen store.
  • promote gluconeogenesis - formation sugar from non-carbohydrate source.
  • blood sugar level rise.
  • increase lipolysis
17
Q

Systemic Effects of Glucocorticoids:
4. Hematopeoietic system - bone marrow

A
  • involution of lymphoid tissue.
  • decrease lymphocytes, monocyte, eosinophil.
  • increase pseudooeutrophilia, platelets, RBC / pseudoneutrophilia: increase count of neutrophil but prevent migrate to tissue.
  • decrease clotting time and phagocyte.
  • increase haemoglobin synthesis.
18
Q

Systemic Effects of Glucocorticoids:
5. Cardiovascular system

A
  • increase epinephrine.
  • positive inotropic effect (increase heart rate).
  • increase blood pressure.
19
Q

Systemic Effects of Glucocorticoids:
6. Kidney

A
  • Increased reabsorption of water, sodium, chloride
  • Increased excretion of potassium, calcium
  • Increased extracellular fluid
20
Q

Systemic Effects of Glucocorticoids:
7. Bone

A
  • Inhibition of collagen synthesis by fibroblasts
  • Antagonism of Vitamin D
21
Q

Systemic Effects of Glucocorticoids:
8. Reproductive Tract

A
  • Parturition induced during the latter part of pregnancy in ruminants and horses.
  • Teratogenesis during early pregnancy.
22
Q

Systemic Effects of Glucocorticoids:
9. Skeletal muscle

A

Weakness due to decrease calcium level

23
Q

Septic shock cause vasodilation, treatment:

A

Treat with corticosteroids.
- increase epinephrine.
- reduce inflammatory mediator.

24
Q

Immunosuppressive effects:

A
  • Decrease T lymphocytes in blood thus reducing cell- mediated immunity.
  • Inhibits hypersensitivity reactions and cell- mediated immunologic functions.
  • Inhibit complement activation and action.
  • Inhibit T and B lymphocyte function and decrease circulating lymphocytes and monocytes.
  • Reduce amount of antigen released by grafted tissue.
  • Delay revascularization.
  • Antiallergic effects (associated with antiinflammatory and immunosupressive effects).
24
Anti inflammatory effect
- Reduce response of neutrophils, eosinophils, and monocytes to chemotactic stimuli. - Suppress neutrophil, monocyte, and eosinophil migration into areas of injury or inflammation. - Increase circulating neutrophils. - Markedly decrease eosinophils, basophils, lymphocytes, andmonocytes.
25
Anti inflammatory effect
- Reduce mast cell accumulation in inflamed area thereby reducing amount of histamine released. - Potentiate vasoconstrictor effects of epinephrine and norepinephrine thus reducing blood flow, redness, and heat. - Reduce capillary permeability thereby reducing plasma loss into inflamed tissues and reducing swelling. - Reduce PGE2 synthesis, decreasing the pain- producing actions of histamine and bradykinin.
26
Anti inflammatory effect
- reduce healing and edema. - Fever and pyrogen reactions are reduced. - Reduce the activity of fibroblasts; deposition of fibrin, deposition of collagen. - Large amounts of corticosteroids stabilize lysosomal membranes inhibiting the release of proteolytic enzymes.
27
اشوف الصورة صفحة 21
ضرورييي كثير
27
Therapeutics uses:
- endocrine (adrenalinsufficiency), - rheumatic (arthritis), - autoimmune disease , inhibit immune system - Allergic states, respiratory diseases (asthma), dermatologic diseases (pemphigus, allergic dermatoses), - Hematologic (thrombocytopenias, autoimmune hemolytic anemias), - Neoplasia.
28
Therapeutics uses:
- nervous system (increased CSF pressure), - GI (ulcerative colitis exacerbations) - renal (nephrotic syndrome). - Endotoxemic shock - Some glucocorticoids are used topically in the eye and skin for various conditions or are injected intraarticularly or intra-lesionally.
29
صفحة 24+25
ضروري
30
Contraindications: ممنوع نعطي بهاي الحالات
- GIT ulcer. - viral and bacterial infection. - Diabetes mellitus. - Corneal ulcers. - Cardiac insufficiencies. - Use cautiously during gestation. - Burns or bleeding ; decreases healing and increases infection rate. - Administration of NSAIDs. (enhance ulcer) يعني ممنوع
31
Adverse reactions: بعد اليوم الخامس بتبلش تظهر
- polydipsia (PD), polyphagia (PP) and polyuria (PU), may all be seen with short-term. - Dullness, dry haircoat, weight gain, panting, vomiting, diarrhea. - elevated liver enzymes, pancreatitis, GI ulceration. - lipidemias. - activation or worsening of diabetes mellitus. - muscle wasting and behavioral changes. - immunosuppressive